Phibro Animal Health | PAHC - Cash And Equivalent

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $55.49M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Align Technology USD 1B 103.43M Sep/2025
ANI Pharmaceuticals USD 262.61M 44.81M Sep/2025
Assertio Holdings USD 38.5M 8.59M Sep/2025
Aurora Cannabis CAD 95.69M 44.47M Sep/2025
Bristol-Myers Squibb USD 10.21B 5.52B Dec/2025
Canopy Growth CAD 298.06M 171.86M Sep/2025
Corcept Therapeutics USD 125.14M 22.39M Sep/2025
Eli Lilly USD 7.27B 2.52B Dec/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Merck USD 18.17B 10.16B Sep/2025
Nektar Therapeutics USD 41.03M 1.96M Sep/2025
Pacira USD 147.59M 152.89M Sep/2025
Phibro Animal Health USD 55.49M 17.28M Dec/2025
Prestige Brands USD 62.37M 56.73M Dec/2025
Supernus Pharmaceuticals USD 151.37M 6.66M Sep/2025
Zoetis USD 2.08B 649M Sep/2025